A detailed history of Ballentine Partners, LLC transactions in Hologic Inc stock. As of the latest transaction made, Ballentine Partners, LLC holds 4,771 shares of HOLX stock, worth $344,179. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,771
Previous 4,632 3.0%
Holding current value
$344,179
Previous $377,000 9.02%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 16, 2025

BUY
$70.76 - $83.72 $9,835 - $11,637
139 Added 3.0%
4,771 $343,000
Q3 2024

Oct 23, 2024

BUY
$73.48 - $83.64 $54,448 - $61,977
741 Added 19.04%
4,632 $377,000
Q2 2024

Aug 06, 2024

SELL
$71.43 - $78.41 $3,571 - $3,920
-50 Reduced 1.27%
3,891 $288,000
Q1 2024

Apr 11, 2024

BUY
$71.33 - $77.96 $19,473 - $21,283
273 Added 7.44%
3,941 $307,000
Q4 2023

Jan 23, 2024

BUY
$65.11 - $72.63 $238,823 - $266,406
3,668 New
3,668 $262,000

Others Institutions Holding HOLX

About HOLOGIC INC


  • Ticker HOLX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 249,652,992
  • Market Cap $18B
  • Description
  • Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The...
More about HOLX
Track This Portfolio

Track Ballentine Partners, LLC Portfolio

Follow Ballentine Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ballentine Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ballentine Partners, LLC with notifications on news.